Laboratory of Molecular & Cardiovascular Physiology
In the Drug Discovery Center

Quantitative proteomics for post-translational modification and histone epigenetics

时间:2015-06-12

June 11, 2005

Dr. Zhongyi Cheng, the CEO of PTM Biolabs Inc, visited our lab and shared his great research experience in quantitative proteomics for post-translational modification and histone epigenetics with us at E104.

IMG_3018

 

IMG_3015